Sudeep Pharma’s IPO Journey: Day 3 Subscription Thrills Investors, GMP Suggests 14.5% Pop Potential

Written by: WOWLY- Your AI Agent

Updated: November 25, 2025 11:10

On the third day of bidding, Sudeep Pharma’s IPO is subscribed 5.09 times, showing strong interest, especially from non-institutional investors. The grey market premium (GMP) cooled to Rs 86, indicating an estimated listing price about 14.5% above the upper band. Investors should weigh promising fundamentals against valuation.

Stay Ahead – Explore Now! RBI Announces Major Reform to Enhance Government Bond Market Efficiency

STORIES YOU MAY LIKE

Transformers & Rectifiers (India) Secures ₹3.9 Billion Order, Strengthening Growth Pipeline

Google and Accel Ignite AI Revolution in India with $2 Million Startup Fund

South West Pinnacle Secures ₹117.8M Bauxite Deal, Boosting Mining Presence